Arcellx, Inc.
ACLXNASDAQHealthcare
$115.07
+$0.02(+0.02%)
Market Cap$6.7B
P/E Ratio—
52W High$115.13
52W Low$50.85
Arcellx, Inc. (ACLX) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
ACLX · earnings · updated Jun 8, 2026
Latest Earnings
Q1 FY2026Report Date: Feb 26, 2026EPS Actual
-$1.01
Est. -$1.01 · +0.0%
Revenue
$0.00B
Est. $0.01B · -65.0%
Fiscal Period
Q1 FY2026
FY ends December
Report Date
Feb 26, 2026
After Market Close
▼ Miss Revenue✓ 1-Quarter EPS Beat Streak
ACLX reports quarterly as a NASDAQ-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$0.07
Rev. $15.39B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$0.07
Rev. Est.$15.39B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q2 FY2026 | May 7, 2026 | -$1.13 | — | — | — | $0.01B | — |
| — Q1 FY2026 | Feb 26, 2026 | -$1.01 | -$1.01 | +0.0% | $0.00B | $0.01B | -65.0% |
| ▼ Q4 FY2025 | Nov 5, 2025 | -$0.96 | -$0.99 | -3.1% | $0.00B | $0.01B | -60.9% |
| ▲ Q3 FY2025 | Aug 7, 2025 | -$1.03 | -$0.94 | +8.7% | $0.01B | $0.01B | -44.9% |
| ▼ Q2 FY2025 | May 8, 2025 | -$0.84 | -$1.13 | -34.5% | $0.01B | $0.01B | -36.8% |
| ▼ Q1 FY2025 | Feb 27, 2025 | -$0.63 | -$0.87 | -38.1% | $0.02B | $0.03B | -40.6% |
| ▲ Q4 FY2024 | Nov 7, 2024 | -$0.54 | -$0.48 | +11.1% | $0.03B | $0.04B | -32.8% |
| ▲ Q3 FY2024 | Aug 8, 2024 | -$0.54 | -$0.51 | +5.6% | $0.03B | $0.02B | +24.3% |
Q2 FY2026
May 7, 2026
EPS Actual
—
EPS Est.
-$1.13
EPS Surpr.
—
Revenue
—
Q1 FY2026
Feb 26, 2026
EPS Actual
-$1.01
EPS Est.
-$1.01
EPS Surpr.
+0.0%
Revenue
$0.00B
Q4 FY2025
Nov 5, 2025Miss
EPS Actual
-$0.99
EPS Est.
-$0.96
EPS Surpr.
-3.1%
Revenue
$0.00B
Q3 FY2025
Aug 7, 2025Beat
EPS Actual
-$0.94
EPS Est.
-$1.03
EPS Surpr.
+8.7%
Revenue
$0.01B
Q2 FY2025
May 8, 2025Miss
EPS Actual
-$1.13
EPS Est.
-$0.84
EPS Surpr.
-34.5%
Revenue
$0.01B
Q1 FY2025
Feb 27, 2025Miss
EPS Actual
-$0.87
EPS Est.
-$0.63
EPS Surpr.
-38.1%
Revenue
$0.02B
Q4 FY2024
Nov 7, 2024Beat
EPS Actual
-$0.48
EPS Est.
-$0.54
EPS Surpr.
+11.1%
Revenue
$0.03B
Q3 FY2024
Aug 8, 2024Beat
EPS Actual
-$0.51
EPS Est.
-$0.54
EPS Surpr.
+5.6%
Revenue
$0.03B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $0.25 | $0.47 | $0.72 | 1 |
| Q3 FY2027 | $-0.30 | $-0.19 | $-0.10 | 1 |
| Q2 FY2027 | $-0.75 | $-0.49 | $-0.26 | 1 |
| Q1 FY2027 | $-0.98 | $-0.64 | $-0.34 | 1 |
| Q4 FY2026 | $-1.57 | $-1.01 | $-0.55 | 1 |
| Q3 FY2026 | $-1.65 | $-1.07 | $-0.57 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $0.1B | $0.2B | $0.2B | 1 |
| Q3 FY2027 | $0.1B | $0.1B | $0.1B | 1 |
| Q2 FY2027 | $0.0B | $0.1B | $0.1B | 1 |
| Q1 FY2027 | $0.0B | $0.0B | $0.1B | 1 |
| Q4 FY2026 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2026 | $0.0B | $0.0B | $0.0B | 1 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q1 FY2026 | Feb 26, 2026 | +0.0% | $113.76 | $113.88 | +0.11% |
| ▼ Q4 FY2025 | Nov 5, 2025 | -3.1% | $88.18 | $87.51 | -0.76% |
| ▲ Q3 FY2025 | Aug 7, 2025 | +8.7% | $70.67 | $71.15 | +0.68% |
| ▼ Q2 FY2025 | May 8, 2025 | -34.5% | $52.94 | $56.26 | +6.27% |
| ▼ Q1 FY2025 | Feb 27, 2025 | -38.1% | $60.26 | $61.39 | +1.88% |
| ▲ Q4 FY2024 | Nov 7, 2024 | +11.1% | $92.98 | $99.16 | +6.65% |
| ▲ Q3 FY2024 | Aug 8, 2024 | +5.6% | $50.91 | $52.58 | +3.28% |
| ▲ Q2 FY2024 | May 9, 2024 | +72.5% | $52.25 | $52.73 | +0.92% |
Q1 FY2026+0.11%
Report Date
Feb 26, 2026
EPS Beat/Miss
+0.0%
Price Before
$113.76
Price After
$113.88
Q4 FY2025-0.76%
Report Date
Nov 5, 2025
EPS Beat/Miss
-3.1%
Price Before
$88.18
Price After
$87.51
Q3 FY2025+0.68%
Report Date
Aug 7, 2025
EPS Beat/Miss
+8.7%
Price Before
$70.67
Price After
$71.15
Q2 FY2025+6.27%
Report Date
May 8, 2025
EPS Beat/Miss
-34.5%
Price Before
$52.94
Price After
$56.26
Q1 FY2025+1.88%
Report Date
Feb 27, 2025
EPS Beat/Miss
-38.1%
Price Before
$60.26
Price After
$61.39
Q4 FY2024+6.65%
Report Date
Nov 7, 2024
EPS Beat/Miss
+11.1%
Price Before
$92.98
Price After
$99.16
Q3 FY2024+3.28%
Report Date
Aug 8, 2024
EPS Beat/Miss
+5.6%
Price Before
$50.91
Price After
$52.58
Q2 FY2024+0.92%
Report Date
May 9, 2024
EPS Beat/Miss
+72.5%
Price Before
$52.25
Price After
$52.73
Avg Beat Reaction+2.33%
Avg Miss Reaction+2.46%
Beat Rate5 / 8 quarters
Largest Move+6.65% (Q4 FY2024)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: ACLX ends December
Arcellx, Inc. (ACLX) most recently reported earnings on February 26, 2026 for Q1 FY2026, posting EPS of $-1.01 (in line with the analyst consensus of $-1.01). The next ACLX earnings date is expected around September 1, 2026.
Each quarter, investors track ACLX earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. ACLX revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
ACLX's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
ACLX earnings · 4 questionsArcellx, Inc.'s next earnings report is expected around September 1, 2026. ACLX typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; ACLX historically reports after market close (AMC).
ACLX earnings datewhen is ACLX earningsACLX next earnings datewhen does ACLX report earningsACLX earnings calendar
▸ Source: FMP · Arcellx, Inc. SEC filings · US GAAP · Arcellx, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026